Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Imagine Lithium: focused on advancing its flagship Jackpot Lithium Property

Imagine Lithium is a Vancouver-based mineral exploration company focused on advancing its flagship Jackpot Lithium Property in Northern Ontario’s Georgia Lake Area. The property contains two historical resources, as well as multiple new pegmatite targe...
Simon Druker | February 13, 2023 |

Hydrogen stocks with top news; Plug, Nucera and DynaCERT in focus

Despite negative quarterly figures, the Plug Power stock has developed positively in recent days. Is this the turnaround for the hydrogen pure play? The Americans recently reported progress on a mega-project. DynaCERT is strengthening its position with an industry ex...
Fabian Lorenz | May 22, 2024 |

Memphasys, Moderna, Paion - Investments in solutions with potential

Biotech companies around the world employ scientists and physicians to study the causes of diseases. The research and development of medical products and solutions usually involves a large number of tests and takes a correspondingly long time. The longer and more extensive thi...
Mario Hose | June 2, 2020 |

Between bankruptcy and multiplication: Cleantech stocks Siemens Energy, Plug Power and dynaCERT

More losses than revenue is never a good sign for any business model. Given the muted reactions to the quarterly figures, Plug Power investors seem to have grown accustomed to this pattern. Despite planned cost reductions, a return to profitability is not yet in sight. St...
Fabian Lorenz | May 27, 2025 |

Key Message from IMF for the Gold Market

The Spring Meeting of the World Bank and the IMF, during which the latter organization released its fresh World Economic Outlook , has just ended. What are the takeaways for the gold market? Stagnation or Acceleration after the Slowdown? In Thursday’s ...
Arkadiusz Sieron | April 16, 2019 |

The Optimist’s Guide to Airlines and Gold

“Travel,” Mahatma Gandhi once said, “is the language of peace.” If that’s the case—and I happen to believe that it is—then I’m extremely bullish about the future, especially with respect to ...
Frank Holmes | October 15, 2019 |

Relmada Therapeutics Stock Soars on Phase 2 Depression Study Results

Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100–200% higher today and the stock was halted several times trading due to extreme price volatility. ...
Streetwise Reports | October 16, 2019 |

Biogen Shares Rebound Strongly on Updated Phase 3 Alzheimer's Data and Q3 Earnings

Shares of Biogen Inc. opened nearly 39% higher today after the firm announced plans to submit a Biologics License Application to the FDA in early 2020 for its Alzheimer's drug aducanumab based on new analysis of larger datasets from two phase 3 studies. The company also anno...
Streetwise Reports | October 23, 2019 |

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia ...

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia Trial Results Syndax Pharmaceuticals' shares traded 30% higher after the company reported it expects to raise $35 million from a common stock offering from five instituti...
Streetwise Reports | February 3, 2020 |

MediciNova Shares Rise 40% on Plans to Initiate COVID-19 ARDS Clinical Trial

Shares of MediciNova traded higher after the company reported that it plans to initiate a clinical study of MN-166 (ibudilast) for COVID-19 acute respiratory distress syndrome. Biopharmaceutical company MediciNova, Inc. yesterday announced that "it will ...
Streetwise Reports | April 13, 2020 |
1 2 3 4 5